What to Do When Clear Success Comes With an Unclear Risk?
- 18 October 2002
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 298 (5593) , 510-511
- https://doi.org/10.1126/science.298.5593.510
Abstract
An expert panel, meeting in an emergency session last week, urged the U.S. Food and Drug Administration to lift a hold it had placed on three gene therapy trials after a patient treated with gene therapy in France developed cancer. The panel made the recommendation after concluding that the cancer was almost certainly caused by the gene therapy.Keywords
This publication has 0 references indexed in Scilit: